Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insight, neurocognitive function and symptom clusters in chronic schizophrenia

A A Collins1, G J Remington, K Coulter

  • 1Schizophrenia Division, Clarke Institute of Psychiatry, Toronto, Canada.

Schizophrenia Research
|November 28, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The adrenergic α2 antagonist atipamezole alters the behavioural effects of pramipexole and increases pramipexole concentration in blood plasma.

Life sciences·2016
Same author

Low dose pramipexole causes D3 receptor-independent reduction of locomotion and responding for a conditioned reinforcer.

Neuropharmacology·2014
Same author

Retrospective evaluation and dating of non-accidental rib fractures in infants.

Clinical radiology·2013
Same author

Credentialling Australian critical care nurses: the pilot study.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2001
Same author

Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study.

Psychopharmacology·2000
Same author

The generation of vibrotactile patterns on a linear array: influences of body site, time, and presentation mode.

Perception & psychophysics·2000
Same journal

Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial.

Schizophrenia research·2026
Same journal

Converting negative symptom dimension scores across SANS and PANSS.

Schizophrenia research·2026
Same journal

Inflammation-associated alterations in mGluR transcript expression in the human nucleus accumbens independent of schizophrenia diagnosis.

Schizophrenia research·2026
Same journal

One social interaction after another: Dynamic modeling of social experience in schizophrenia.

Schizophrenia research·2026
Same journal

Reduced synaptic plasticity and E/I imbalance drive peripersonal space boundaries expansion in schizophrenia.

Schizophrenia research·2026
Same journal

Complete blood count-derived inflammatory markers and symptom phenotypes in schizophrenia spectrum disorders: A hierarchical clustering analysis.

Schizophrenia research·2026
See all related articles

Insight in schizophrenia is linked to positive symptoms, not neurocognitive deficits. This study found positive symptoms significantly predict awareness of illness in chronic schizophrenia patients.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Clinical Psychology

Background:

  • Insight, or awareness of illness, is crucial for treatment adherence in schizophrenia.
  • Previous research has explored links between insight, psychopathology, and neurocognition, but findings are inconsistent.

Purpose of the Study:

  • To investigate the relationship between psychopathological symptoms, neurocognitive deficits, and insight in chronic schizophrenia.
  • To determine the predictive value of specific symptom clusters and neurocognitive performance on insight.

Main Methods:

  • Fifty-eight chronic schizophrenia outpatients were assessed.
  • Measures included David's Schedule for Assessing Insight, Positive and Negative Syndrome Scale (PANSS), Calgary Depression Scale, and Wisconsin Card Sorting Test (WCST).

Related Experiment Videos

Main Results:

  • A significant association was found between psychopathological symptoms, neurocognitive deficits, and insight.
  • Positive symptoms of schizophrenia were the most significant predictors of insight.
  • Negative symptoms and neurocognitive deficits (WCST performance) did not significantly predict insight.

Conclusions:

  • Unawareness of illness in schizophrenia is not solely a product of frontal lobe dysfunction.
  • Positive symptoms play a more critical role in insight deficits than negative symptoms or neurocognitive impairments.